Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter

Investor News

Clinical Development News
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
Approvable Letters
Approval and Marketing Clearance
Recalls and Warnings

Deals & Dollars News
Earnings Reports
Mergers and Acquisitions

IPO News

Biotech/Pharma - Investor
Bellicum Pharmaceuticals, Inc. Prices Initial Public Offering Of 7,350,000 Shares Of Common Stock 12/18/2014 11:50:19 AM
Biotech Predictions for Large Cap Firms Include Medivation, Inc. (MDVN), Gilead Sciences, Inc. (GILD) 12/18/2014 12:15:08 PM
Xenetic Biosciences CEO Delivers “2014 – The Year In Review” Update To Investors And Stakeholders 12/18/2014 10:43:42 AM
Xenetic Biosciences CEO Delivers “2014 – The Year In Review” Update To Investors And Stakeholders 12/18/2014 9:28:47 AM
CytoSorbents, Inc. Receives NASDAQ Listing Approval 12/18/2014 8:31:57 AM
Cara Therapeutics, Inc. (CARA) Announces Addition To The NASDAQ Biotechnology Index 12/18/2014 8:07:37 AM
Trillium Therapeutics Inc. To List Common Shares On The NASDAQ Capital Market Under The Symbol TRIL 12/18/2014 7:44:36 AM
PTC Therapeutics, Inc. (PTCT) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 12/18/2014 7:44:02 AM
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) Completes Public Offering of Common Stock 12/18/2014 7:42:58 AM
2015 Could Be Blockbuster Year for Alkermes plc (ALKS), Says Citi 12/17/2014 3:03:51 PM
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 12/17/2014 12:09:35 PM
Novogen Limited (NVGN) Raises A$4.1 Million In Private Placement To US Institutions 12/17/2014 9:20:05 AM
IGI Laboratories, Inc. Announces Closing Of $125 Million Of 3.75% Convertible Senior Notes Due 2019 12/17/2014 10:05:35 AM
LifeSci Index Partners, LLC Release: BioShares Launches Two New Biotechnology ETFs (Nasdaq: BBC, BBP) 12/17/2014 8:03:11 AM
Flexion Therapeutics (FLXN) Announces Exercise Of Underwriters' Over-Allotment Option And Closing Of Public Offering Of Common Stock 12/17/2014 7:47:55 AM